1. Home
  2. MYPS vs NSPR Comparison

MYPS vs NSPR Comparison

Compare MYPS & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MYPS
  • NSPR
  • Stock Information
  • Founded
  • MYPS 2011
  • NSPR 2005
  • Country
  • MYPS United States
  • NSPR United States
  • Employees
  • MYPS N/A
  • NSPR N/A
  • Industry
  • MYPS EDP Services
  • NSPR Medical/Dental Instruments
  • Sector
  • MYPS Technology
  • NSPR Health Care
  • Exchange
  • MYPS Nasdaq
  • NSPR Nasdaq
  • Market Cap
  • MYPS 114.4M
  • NSPR 99.7M
  • IPO Year
  • MYPS N/A
  • NSPR N/A
  • Fundamental
  • Price
  • MYPS $0.82
  • NSPR $2.13
  • Analyst Decision
  • MYPS Buy
  • NSPR Strong Buy
  • Analyst Count
  • MYPS 4
  • NSPR 2
  • Target Price
  • MYPS $2.00
  • NSPR $4.50
  • AVG Volume (30 Days)
  • MYPS 209.0K
  • NSPR 70.2K
  • Earning Date
  • MYPS 11-03-2025
  • NSPR 11-04-2025
  • Dividend Yield
  • MYPS N/A
  • NSPR N/A
  • EPS Growth
  • MYPS N/A
  • NSPR N/A
  • EPS
  • MYPS N/A
  • NSPR N/A
  • Revenue
  • MYPS $247,477,000.00
  • NSPR $7,779,000.00
  • Revenue This Year
  • MYPS N/A
  • NSPR $7.48
  • Revenue Next Year
  • MYPS N/A
  • NSPR $104.39
  • P/E Ratio
  • MYPS N/A
  • NSPR N/A
  • Revenue Growth
  • MYPS N/A
  • NSPR 14.04
  • 52 Week Low
  • MYPS $0.79
  • NSPR $1.99
  • 52 Week High
  • MYPS $2.29
  • NSPR $3.80
  • Technical
  • Relative Strength Index (RSI)
  • MYPS 21.60
  • NSPR 30.59
  • Support Level
  • MYPS $0.94
  • NSPR $2.10
  • Resistance Level
  • MYPS $0.95
  • NSPR $2.41
  • Average True Range (ATR)
  • MYPS 0.03
  • NSPR 0.11
  • MACD
  • MYPS -0.01
  • NSPR -0.01
  • Stochastic Oscillator
  • MYPS 16.65
  • NSPR 20.27

About MYPS PLAYSTUDIOS Inc.

PLAYSTUDIOS Inc is engaged in gaming and related business. The Company develops and operates online and mobile social gaming applications (games or game), many of which incorporate a loyalty program offering real world rewards provided by a collection of awards partners. The Company's games are free-to-play and available via the Apple App Store, Google Play Store, Amazon Appstore and Facebook (collectively, platforms or platform operators). The Company creates games based on its own original content as well as third-party licensed brands. The Company generates revenue through the in-game sales of virtual currency and through advertising. The company has one operating segment with one business activity, developing and monetizing social games.

About NSPR InspireMD Inc.

InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.

Share on Social Networks: